PGS Advantages vs Microscopic Embryo Selection: Dr. Robert Anderson| Illumina Video

9 March 2015

Preimplantation genetic screening (PGS) is advancing reproductive genetic health. Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses pregnancy rates achieved with PGS embryo selection compared to conventional microscopic embryo evaluation. Learn more at:
http://clinical.illumina.com/clinical/reproductive-genetic-health.html

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.